Hangzhou HeZheng Pharmaceutical Co., Ltd Report issue

For profit Phase 1
Founded: Hangzhou China (1995)

Organization Overview

First Clinical Trial
2019
NCT04173455
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Hangzhou HeZheng Pharmaceutical Co., Ltd

Active Ingredients

Drugs in Phase 1 Trials (1)

hz-a-018 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lymphoma (Phase 1)

Lymphoma, B-Cell (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1